Phase III trial of bucindolol in patients with chronic heart failure selected based on genotype.
Phase of Trial: Phase III
Latest Information Update: 27 May 2011
At a glance
- Drugs Bucindolol (Primary) ; Metoprolol succinate
- Indications Chronic heart failure
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors ARCA biopharma Inc
- 24 Nov 2009 New trial record.